Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2009

View Archived Issues

Novel beta-secretase 1 inhibitors developed by Schering-Plough for AD therapy

Potent dual orexin receptor antagonist SB-649868 shows hypnotic properties in multiple studies

Novartis reports trial results of adjuvanted cell culture-based influenza A(H1N1) vaccine

Autologous immunosuppressive regulatory B cells show promise in autoimmune disease therapy in vivo

DTriP-22 shows potent anti-enterovirus 71 activity by inhibiting NS5B

Andrographolide analogue exhibits significant antibacterial activity

FDA Advisory Committee recommends approval of romidepsin for cutaneous T-cell lymphoma

Takeda presents results from first quarter of 2009, ending June 30

OSI initiates two clinical trials of OSI-906

GSK claims AMPA glutamate receptor ligands for psychotic disorders

FDA grants Cytopia clearance for CYT-387 trials in U.S.

Enanta identifies novel hepatitis C virus NS3 NS4A protease inhibitors

Phase II study suggests telmisartan may reverse epirubicin cardiotoxicity in cancer patients

Sanwa describes thyroid hormone receptor ligands for the treatment of hyperlipidemia

Taiho presents retinoid RARalpha receptor agonists as antitumor agents

Grifols launches anti-hepatitis B immunoglobulin, Niuliva

Endo launches Valstar for bladder cancer

Takeda receives FDA complete response letter for fixed-dose Actos and alogliptin benzoate

FDA accepts for review Bristol-Myers Squibb's BLA for belatacept

FDA issues warning for Myfortic

Array BioPharma reports topline results from phase II ARRY-162 trial

Dilafor reports phase II tafoxiparin results in preventing protracted labor

Acura and King Pharmaceuticals provide update on Acurox NDA

Shionogi reports results from first quarter 2009, ended June 30

Japanese launch for GSK's dutasteride for benign prostatic hyperplasia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...